CCR2 and early-onset autosomal dominant Alzheimer disease: Scores of studies have been made on the influence of CCR2 and its ligands on various inflammatory diseases of the central nervous system, covering multiple sclerosis (MS), Alzheimer’s disease, and ischemic stroke[15].